Issue Information
Rationale for combinatory chronic lymphocytic leukaemia treatment paradigms in the era of the B‐cell receptor pathway and anti‐apoptotic inhibitors
Human monopoiesis is characterized by distinct and stage‐specific gene expression profiles
Classical Hodgkin lymphoma producing macrophage colony‐stimulating factor with resultant monocytosis
Cholecystitis as the initial presentation of acute myeloid leukaemia
Statistical reporting in the BJH
Approach to patients with essential thrombocythaemia and very high platelet counts
Guidelines for the use of platelet transfusions
The diagnosis and management of primary autoimmune haemolytic anaemia
Ublituximab (TG‐1101), a novel glycoengineered anti‐CD20 antibody, in combination with ibrutinib is safe and highly active in patients with relapsed and/or refractory chronic lymphocytic leukaemia
Sequential chemotherapy followed by reduced‐intensity conditioning and allogeneic haematopoietic stem cell transplantation in adult patients with relapse or refractory acute myeloid leukaemia
A phase IIb trial of vorinostat in combination with lenalidomide and dexamethasone in patients with multiple myeloma refractory to previous lenalidomide‐containing regimens
Increased regulatory T cell graft content is associated with improved outcome in haematopoietic stem cell transplantation
Maturation‐associated gene expression profiles along normal human bone marrow monopoiesis
The evolutionary and clinical implications of the uneven distribution of the frequency of the inherited haemoglobin variants over short geographical distances
Longitudinal evaluation of cerebral white matter hyperintensities lesion volume in children with sickle cell disease
Clonal Replacement Underlies Spontaneous Remission in Paroxysmal Nocturnal Haemoglobinuria
Clinical significance of TFR2 and EPOR expression in bone marrow cells in myelodysplastic syndromes
Pathognomonic serum cytokine profiles identify life‐threatening langerhans cell histiocytosis
Prognostic importance of CD56 expression in intermediate risk acute myeloid leukaemia
Review of ‘Personalized Immunosuppression in Transplantation’ Edited by Michael Oellerich and Amitava Dasgupta